Related Experiment Video

Updated: Jan 29, 2026

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis
05:39

A Neonatal BALB/c Mouse Model of Necrotizing Enterocolitis

Published on: November 30, 2021

4.1K

Fulminant necrotizing fasciitis caused by Aeromonas sobria in neutropenic patients

Hung Chang1, Yu-Shin Hung, Shian-Sen Shie

  • 1School of Medicine, Chang Gung University, Taiwan.

Internal Medicine (Tokyo, Japan)
|December 5, 2012
PubMed

Insights

Fulminant necrotizing fasciitis caused by Aeromonas sobria is a rare but fatal infection in neutropenic patients. Early quinolone treatment and surgery are crucial for survival.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Critical Care Medicine

Background:

  • Neutropenic patients are susceptible to infections, including those caused by Aeromonas species.
  • Necrotizing fasciitis is an uncommon but severe complication, particularly in immunocompromised individuals.

Observation:

  • Three cases of fulminant necrotizing fasciitis caused by Aeromonas sobria in neutropenic patients are presented.
  • Clinical features included shock, coagulopathy, multiple organ failure, and rapid deterioration.
  • Aeromonas sobria isolates demonstrated resistance to most antibiotics, with susceptibility only to quinolones.

Findings:

  • Aeromonas sobria can cause a distinctive and fatal necrotizing fasciitis in neutropenic patients.
  • The infection is characterized by rapid progression and high mortality.
  • Antibiotic resistance patterns highlight the importance of targeted therapy.

Implications:

  • Early recognition and prompt treatment with quinolones, alongside surgical intervention, may improve outcomes.
  • Current antibiotic strategies for febrile neutropenia may need adjustment upon culture availability.
  • This entity requires heightened clinical suspicion in neutropenic patients presenting with severe soft tissue infections.

More Related Videos

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis08:42

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

8.2K
Evaluating Virulence and Pathogenesis of Aeromonas Infection in a Caenorhabditis elegans Model06:15

Evaluating Virulence and Pathogenesis of Aeromonas Infection in a Caenorhabditis elegans Model

Published on: December 20, 2018

8.0K

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
269
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
301
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
263
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
234
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
3.0K